Related Experiment Video

Updated: Oct 17, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
12:29

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus

Published on: April 19, 2017

Treatment of fungal infections with ABLC in the home-care setting

A C Weissmann

    The Journal of the Association of Nurses in AIDS Care : JANAC
    |March 9, 2000
    PubMed

    Insights

    Lipid formulations of amphotericin B are effective for invasive fungal infections in HIV patients, offering a safer home infusion alternative. These alternatives reduce nephrotoxicity compared to conventional amphotericin B.

    Area of Science:

    • Mycology
    • Infectious Diseases
    • HIV Medicine

    Background:

    • Invasive fungal infections (IFIs) significantly contribute to morbidity and mortality in individuals with HIV.
    • Home-care management of opportunistic infections presents psychological and economic benefits over hospitalization.
    • Conventional amphotericin B, a standard IFIs treatment, causes adverse reactions like nephrotoxicity, hindering home infusion.

    Purpose of the Study:

    • To evaluate lipid formulations of amphotericin B as a viable alternative for home infusion therapy in HIV-infected individuals.
    • To compare the efficacy and safety profile of lipid formulations against conventional amphotericin B.

    Main Methods:

    • Review of clinical experience with amphotericin B lipid complex injection.
    • Comparison of efficacy, nephrotoxicity rates, and infusion times with conventional amphotericin B.

    Main Results:

    • Lipid formulations of amphotericin B demonstrate comparable efficacy to the conventional form.
    • Lipid formulations exhibit significantly lower rates of nephrotoxicity.
    • Reduced infusion times are observed with lipid formulations compared to conventional amphotericin B.

    Conclusions:

    • Amphotericin B lipid complex injection is an effective alternative to conventional amphotericin B for home infusion therapy.
    • Lipid formulations offer a safer and more manageable treatment option for invasive fungal infections in HIV patients receiving home care.

    More Related Videos

    Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth11:06

    Daily Phototherapy with Red Light to Regulate Candida albicans Biofilm Growth

    Published on: April 23, 2019

    Related Concept Videos

    Antifungal Agents01:15

    Antifungal Agents

    Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
    Candidiasis01:20

    Candidiasis

    Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Fungal Phylum Ascomycota01:28

    Fungal Phylum Ascomycota

    Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
    Fungal Phylum Microsporidia01:28

    Fungal Phylum Microsporidia

    Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
    Skin Diseases and Disorders01:23

    Skin Diseases and Disorders

    Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
    Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...